Therapeutic treatments for neuropsychiatric disorders
AssigneeAllergan Sales, Inc.
InventorStephen Donovan
Life of this patent
Estimating the term…
Abstract
Methods for treating psychiatric disorders include intracranial administration of a therapeutically effective amount of a neurotoxin, such as a botulinum toxin type A, to a human patient.
Claims28
A method for treating a neuropsychiatric disorder, the method comprising a step of intracranial administration of a Clostridial neurotoxin to a patient, thereby alleviating at least one symptom of a neuropsychiatric disorder.
A method for treating a neuropsychiatric disorder, the method comprising a step of intracranial administration of a therapeutically effective amount of a botulinum toxin to a patient, thereby treating a symptom of the neuropsychiatric disorder.
A method for treating a neuropsychiatric disorder, the method comprising a step of intracranial administration of a therapeutically effective amount of a botulinum toxin to a patient, thereby treating a symptom of the neuropsychiatric disorder by reducing neurotransmitter release from neurons contributing to the symptom of the disorder within about four months from the administration of the botulinum toxin.
A method for treating schizophrenia, the method comprising a step of intracranial administration of a therapeutically effective amount of a botulinum toxin to a patient, thereby treating a positive symptom of schizophrenia.
Dependencies are inferred from the claim text.